ALDH1A2 suppresses epithelial ovarian cancer cell proliferation and migration by downregulating STAT3
Yichen Wang, Feng Shao, Lu Chen Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou, China Abstract: Epithelial ovarian cancer is the deadliest gynecological malignancy worldwide. A better understanding of epithelial ovarian cancer pathogenesis and the molecular mechanism underl...
Main Authors: | Wang Y, Shao F, Chen L |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-01-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/aldh1a2-suppresses-epithelial-ovarian-cancer-cell-proliferation-and-mi-peer-reviewed-article-OTT |
Similar Items
-
Early responses of the STAT3 pathway to platinum drugs are associated with cisplatin resistance in epithelial ovarian cancer
by: W.J. Sheng, et al.
Published: (2013-08-01) -
Dual inhibition of EGFR and IL-6-STAT3 signalling by miR-146b: a potential targeted therapy for epithelial ovarian cancer
by: Meina Yan, et al.
Published: (2021-01-01) -
Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 Pathway
by: Shin-Yi Chung, et al.
Published: (2021-07-01) -
Down-regulation of PADI2 prevents proliferation and epithelial-mesenchymal transition in ovarian cancer through inhibiting JAK2/STAT3 pathway in vitro and in vivo, alone or in combination with Olaparib
by: Lidong Liu, et al.
Published: (2020-09-01) -
Anti-Proliferation Effect of Theasaponin E1 on the ALDH-Positive Ovarian Cancer Stem-Like Cells
by: Ling-Yan Jia, et al.
Published: (2018-06-01)